Infants dyschezia.
Conditions
Interventions
Intervention 1: The cases group will receive (oral extemporaneous pharmacy-made Ploxamer with a dose of 1 mg/kg one time per day) for 2 weeks
the quality of treatment will be assessed at the next visit based on the child's mother's report in terms of the number of bowel movements and the presence or absence of difficulty in defecation. Inte
the quality of treatment was assessed at the next visit based on the child's mother's report in terms of the number of bowel movements and the presence or absence of difficulty in defecation.
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
1 Months to 24 Months
Inclusion criteria
Inclusion criteria: All infants (more than 30 days old) with dyschezia and without organic reasons for it, patients also should not have been treated for it in the past week before the intervention
Exclusion criteria
Exclusion criteria: Parents request for exclusion any previous PEG3350 related hypersensitivity any previous Poloxamer 188 related hypersensitivity
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Defication frequency and difficulty. Timepoint: Before and after the study with a 2 weeks interval. Method of measurement: Observation , counting and Visual analog scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAli Mohammad Sabzghabaee
Esfahan University of Medical Sciences
Outcome results
None listed